Table 2.

Characteristics of COVID-19 Hospitalizations

Clinical characteristic	All patients	ICU admission			In-hospital mortality
		Non-ICU	ICU	P	Alive	Hospital death	P
Management
Prone positioning	1457 (15.1%)	619 (8.3%)	838 (37.6%)	<0.001	1158 (13.1%)	299 (37.2%)	<0.001
Mechanical ventilation	978 (10.1%)	0 (0.0%)	978 (43.9%)	<0.001	578 (6.5%)	400 (49.8%)	<0.001
Hemodialysis	424 (4.4%)	224 (3.0%)	200 (9.0%)	<0.001	342 (3.9%)	82 (10.2%)	<0.001
Convalescent plasma	630 (6.5%)	434 (5.9%)	196 (8.8%)	<0.001	538 (6.1%)	92 (11.4%)	<0.001
Anticoagulation	8647 (89.6%)	6522 (87.9%)	2125 (95.3%)	<0.001	7927 (89.6%)	720 (89.6%)	<0.001
Glucocorticosteroids	6009 (62.3%)	4328 (58.4%)	1681 (75.4%)	<0.001	5356 (60.6%)	653 (81.2%)	<0.001
Hydroxychloroquine	768 (8.0%)	482 (6.5%)	286 (12.8%)	<0.001	674 (7.6%)	94 (11.7%)	<0.001
Remdesivir	2358 (24.4%)	1870 (25.2%)	488 (21.9%)	0.001	2205 (24.9%)	153 (19.0%)	<0.001
ICU admission	2230 (23.1%)	0 (0%)	2230 (100%)	<0.001	1619 (18.3%)	611 (76.0%)	<0.001
Complications
Anemia	6947 (72.0%)	5013 (67.6%)	1934 (86.7%)	<0.001	6249 (70.7%)	698 (86.8%)	<0.001
Renal failure	2877 (29.8%)	1514 (20.4%)	1363 (61.1%)	<0.001	2333 (26.4%)	544 (67.7%)	<0.001
Bacterial co-infections	651 (6.8%)	364 (4.9%)	287 (12.9%)	<0.001	538 (6.1%)	113 (14.1%)	<0.001
ARDS	364 (3.8%)	26 (0.4%)	338 (15.2%)	<0.001	203 (2.3%)	161 (20.0%)	<0.001
Hospitalization outcomes
Discharge status				<0.001			NA
Alive	8453 (87.6%)	6964 (93.9%)	1489 (66.8%)		NA	NA
Dead	804 (8.3.%)	193 (2.6%)	611 (27.4%)		NA	NA
Remain hospitalized	390 (4.0%)	260 (3.5%)	130 (5.8%)		NA	NA
Hospitalization duration (days)	5 (3, 9)	5 (3, 7)	11 (6, 18)	<0.001	5 (3, 9)	10 (4, 16)	<0.001
ICU duration (days)	5 (2, 11)	NA	5 (2, 11)	NA	4 (2, 9)	8 (3, 14)	<0.001
In-hospital mortality	804 (8.3%)	193 (2.6%)	611 (27.4%)	<0.001	0 (0%)	804 (100%)	NA

Data presented as n (%) or median (interquartile range).

ARDS, acute respiratory distress syndrome; ICU, intensive care unit.